This is a StreetInsider.com Premium Only Page

Hollywood Media Corp. (HOLL) –

Dec 14, 2021 09:00 AM Hollister Biosciences Inc. Launches Rebrand to Yourway Cannabis Brands Inc. and Bold New Strategy

Nov 29, 2021 07:21 PM Hollister Biosciences Announces Third Quarter Fiscal 2021 Financial Results Including Revenue of USD $14.5M and Adjusted Ebitda of USD $1.2M

Nov 23, 2021 03:00 PM Hollister Biosciences Inc. Announces Results of Its 2021 Annual General and Special Shareholder Meeting

Nov 18, 2021 09:09 PM Hollister Biosciences Inc. to Report Q3 2021 Financial Results on November 29, 2021

Nov 2, 2021 08:00 AM Hollister Announces Receipt of Decision from Ontario Securities Commission

Oct 12, 2021 08:00 AM Hollister Biosciences Inc. Announces strategic initiatives including a planned rebrand, executive and board updates

Aug 31, 2021 08:00 AM Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original "Shark" from the NBC hit TV series "Shark Tank" and Jakob Ripshtein, the fo

Aug 26, 2021 09:05 AM Hollister Biosciences Inc. Reports Q2 2021 Financial Results including USD $17.6 million revenue, and USD $3.2 million of Adjusted EBITDA

Aug 25, 2021 09:00 AM Hollister Biosciences Inc. Announces 30-Acre Arizona Brand Campus with planned 700,000 square feet of cultivation area and an existing 28,500-square-foot processing and manufacturing facility

Jul 13, 2021 08:00 AM Hollister Biosciences Inc. Added to Horizons US Marijuana Index ETF and Included in Solactive US Marijuana Companies Index

Jun 28, 2021 08:00 AM Hollister Biosciences Inc. Announces Launch of Pre-Roll Production and Distribution in Arizona

Jun 1, 2021 08:03 AM Hollister Biosciences Inc. Reports First Quarter 2021 Financial Results

May 31, 2021 10:00 AM Hollister Biosciences Inc. Reports Fourth Quarter and Full Year Financial Results

May 17, 2021 11:00 AM Hollister and Heavy Grass Collaborate with Slipknot Co-Founder Shawn "Clown" Crahan on New HashBone Line

Apr 13, 2021 06:05 AM Form D/A HOLLISTER BIOSCIENCES

Apr 8, 2021 09:00 AM The First Round of Easyriders Products Hit Shops this Month

Apr 5, 2021 09:00 AM Hollister Biosciences Inc. Announces Exclusive Distribution Partnership with Nabis for Expanded Market Reach Across California

Mar 16, 2021 03:22 PM Form D HOLLISTER BIOSCIENCES

Mar 8, 2021 05:00 PM Dreamy Delivery Announced as the Official Delivery Platform of the 2021 Emerald Cup Awards

Jan 25, 2021 08:00 AM Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 millio

Jan 7, 2021 09:14 PM /C O R R E C T I O N from Source -- Hollister Biosciences Inc./

Jan 7, 2021 09:14 PM Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

Dec 22, 2020 07:00 AM Hollister Biosciences Inc.'s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California

Dec 15, 2020 07:00 AM Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line

Dec 14, 2020 08:55 AM Allied Corp. and Hollister Biosciences Have Now Delivered TACTICAL RELIEF™ Products into Distribution

Dec 10, 2020 07:00 AM Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Final $40 Million Revenue Milestone

Dec 8, 2020 12:41 PM Hollister Biosciences Inc. Wholly Owned subsidiary Hollister Cannabis Co Receives Trademark Approval for Brand HashBone

Nov 10, 2020 08:00 AM Hollister Biosciences Inc. Launches Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery

Nov 4, 2020 08:00 PM Hollister Provides Comment on Approval of Recreational Cannabis in Arizona

Oct 27, 2020 08:00 AM Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

Oct 6, 2020 08:00 AM Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone

Sep 11, 2020 06:52 PM Hollister Biosciences Retains Renmark Financial Communications Inc.

Aug 25, 2020 02:39 PM Form D HOLLISTER BIOSCIENCES

Aug 24, 2020 08:00 AM Hollister Biosciences Inc. Reports Second Quarter 2020 Results

Aug 5, 2020 08:00 AM Hollister Biosciences Inc. and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement

Jul 14, 2020 07:55 PM Hollister Biosciences Inc. Provides Update on Q2 2020 Performance and Announces Distribution License Renewal

Jun 26, 2020 02:00 AM Hollister Biosciences Inc. and Allied Corp. sign Definitive Agreement for Distribution of Products Under Veteran Based Brand: Tactical Relief™

Jun 26, 2020 02:00 AM Hollister Biosciences Inc. and Allied Corp. sign Definitive Agreement for Veteran Based Brand: Tactical Relief™

Jun 15, 2020 06:38 PM Hollister Biosciences Announces Delay in Filing Annual Financial Statements

Jun 11, 2020 02:00 AM Hollister Bioscience's 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020

Jun 4, 2020 02:00 AM Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

Jun 2, 2020 02:00 AM Hollister Biosciences Inc. Provides Update on Venom's Q1 2020 Performance

May 27, 2020 10:50 AM Hollister Biosciences Inc.'s Division Hollister Cannabis Co. Launches Tommy Chong's Cannabis 1:1 Full-Spectrum Elixir

May 13, 2020 09:00 PM Hollister Biosciences Inc. CEO Provides Corporate Update

Apr 30, 2020 08:00 AM Hollister Biosciences Closes Acquisition of AlphaMind Brands Inc.

Apr 23, 2020 08:00 AM Hollister Biosciences Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc.

Apr 20, 2020 06:00 AM Hollister Biosciences Inc. Division Hollister Cannabis Co Becomes Official Brand Partner for Chronic Relief 4/20 Fundraiser in Support of Feeding America

Apr 14, 2020 06:00 AM Hollister Biosciences Inc. Announces DTC Eligibility

Apr 1, 2020 02:02 PM Form D HOLLISTER BIOSCIENCES

Mar 30, 2020 03:15 AM Hollister Biosciences Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA